Identification and susceptibility of Rhizomucor spp. isolated from patients with cutaneous zygomycosis in China

Medical Mycology

Volumn 49, Issue 8, 2011, Pages 799-805

  Wang, Si Bu ^a   Li, Ruo Yu ^a   Yu, Jin ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Antifungal susceptibility testing; Molecular identification; Morphology; Zygomycetous fungi

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICAFUNGIN; TERBINAFINE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CHINA; CONTROLLED STUDY; FUNGAL MORPHOLOGY; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; IN VITRO STUDY; MUCORALES; NONHUMAN; NUCLEOTIDE SEQUENCE; RHIZOMUCOR; RHIZOMUCOR CHLAMYDOSPORUS; RHIZOMUCOR REGULARIOR; RHIZOMUCOR VARIABILIS; ZYGOMYCOSIS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; BASE SEQUENCE; CHINA; DERMATOMYCOSES; DNA, RIBOSOMAL; DNA, RIBOSOMAL SPACER; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUCORMYCOSIS; PHYLOGENY; RHIZOMUCOR; RNA, RIBOSOMAL, 5.8S; SEQUENCE ANALYSIS, DNA;

ABSIDIA; FUNGI; MUCOR; RHIZOMUCOR; RHIZOMUCOR VARIABILIS; RHIZOPUS;

EID: 80054708689     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2011.571292     Document Type: Article

References (40)

1. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634-653. (Pubitemid 41170352)
2. Cantatore-Francis JL, Shin HT, Heilman E, Glick SA. Primary cutaneous zygomycosis in two immunocompromised children. Pediatr Dermatol 2007; 24: 257-262. (Pubitemid 46848948)
3. Ledgard JP, van Hal S, Greenwood JE. Primary cutaneous zygo-mycosis in a burns patient: a review. J Burn Care Res 2008; 29: 286-290. (Pubitemid 351498821)
4. Liao WQ, Yao Z Y, Li ZQ, Xu H, Zhao J. Sporanox in the treatment of gangrenous pyoderma due to Rhizopus arrizus [in Chinese]. Chin J Dermatol 1994; 27: 259-260.
5. Losee JE, Selber J, Vega S, et al. Primary cutaneous mucormycosis: guide to surgical management. Ann Plast Surg 2002; 49: 385-390.
6. Meng CR, Li H, Wang ZD. Mucormycosis due to Mucor racemosus after skin grafting [in Chinese]. Chin J Clin Laboratory Science 2006; 24: 223.
7. Song KR, Wong MS, Yeung C. Primary cutaneous zygomycosis in an immunodef cient infant: a case report and review of the literature. Ann Plast Surg 2008; 60: 433-436. (Pubitemid 351440814)
8. Wang CY, Zhou SH, Zhang LL, Liu B, Pan AJ. Cutaneous mucormycosis secondary to severe multiple trauma: one case report [in Chinese]. Chin J infect Chemother 2008; 8: 441-442.
9. Zhao ZL, Zhang SP, Wei GY, Tang HS, Zhu YY. Cutaneous mucormycosis secondary to epidermolysis bullosa type of drug eruption [in Chinese]. Chin J Dermatol 2002; 35: 160.
10. Zhong BY, Hao F, Xu YS, et al. A case of contacted dermatitis with secondary infection of Rhizopus arrizus [in Chinese]. Chin J Derm Venereol 2003; 17: 398-399.
11. Zhong H, Wang L, Zhong BY, et al. A case report of primary cutaneous mucormycosis [in Chinese]. Chin J Mycol 2009; 14: 158-159.
12. Cao YC, Chen XP, Zeng XS, et al. A case of deep mycosis caused by Rhizomucor chlamydosporus [in Chinese]. Chin J Dermatol 2007; 40: 659-662.
13. Fu MH, Chen H, Song LY, et al. Facial mucormycosis due to Rhizo-mucor variabilis: a case report [in Chinese]. Int J Dermatol Venereol 2006; 32: 67-69.
14. Jiang X, Wang S, Zhao TJ, Ran YP. Cutaneous mucormycosis: a case report [in Chinese]. J Clin Dermatol 2003; 32: 271.
15. Lechevalier P, Hermoso DG, Carol A, et al. Molecular diagnosis of Saksenaea vasiformis cutaneous infection after scorpion sting in an immunocompetent adolescent. J Clin Microbiol 2008; 46: 3169-3172.
16. Li CY, Xu YH, Hu QF. A case report of facial mucormycosis due to Rhizomucor variabilis [in Chinese]. Chin J Mycol 2006; 1: 284-286.
17. Li CY, Li Y, Hu ZM. A case report of primary cutaneous mucormy-cosis caused by Rhizomucor variabilis [in Chinese]. J Clin Dermatol 2004; 33: 158-160.
18. Lu XL, Liu ZH, Shen YN, et al. Primary cutaneous zygomycosis caused by Rhizomucor variabilis: a new endemic zygomycosis? A case report and review of 6 cases reported from China. Clin Infect Dis 2009; 49: e39-e43.
19. Qin W, Lu S, Que DM, Xi LY, Li XQ. A case report of primary cutaneous mucormycosis caused by Rhizomucor variabilis [in Chinese]. Diag Ther J Dermato-venereo 2010; 17: 14-17.
20. Stewardson AJ, Holmes NE, Ellis DH, Howden BP. Cutaneous zygomycosis caused by Saksenaea vasiformis following water-related wound in a 24-year-old immunocompetent woman. Mycoses 2009; 52: 547-549.
21. Wang AP, Li RY, Wang DL, et al. A case report of destructive muco-cutaneous mucormycosis caused by Rhizomucor variabilis var. regu-larior [in Chinese]. Chin J Dermatol 1994; 27: 51-52.
22. Wang JJ, Zhang QQ, Li L. A case report of primary cutaneous mucormycosis caused by Mucur racemosus [in Chinese]. Chin J Dermatol 2002; 35: 413.
23. Wang JJ, Liao YX. Spoeranox in the treatment of primary cutaneous mucormycosis: report of facase [in Chinese]. J Clin Dermatol 1999; 28: 174-176.
24. Li CL, Wu L, Hao XD, et al. Primary cutaneous mucormycosis caused by Rhizomucor variabilis [in Chinese]. Chin J Pathol 1994; 23: 176-177.
25. Yang XM, Wang YX, Geng SY, et al. Entomophthoromycosis caused by Conidiobolus coronatus (in Chinese). Chin J Dermatol 2006; 39: 442-444.
26. Zhao Y, Zhang Q, Li L, et al. Primary cutaneous mucormycosis caused by Rhizomucor variabilis in an immunocompetent patient. Mycopathologia 2009; 168: 243-247.
27. Zheng RY, Chen CQ. A non-thermophilic Rhizomucor causing human primary cutaneous mucormycosis. Mycosystema 1991; 4: 45-57.
28. Zheng RY, Chen CQ. Another non-thermophilic Rhizomucor causing human primary cutaneous mucormycosis. Mycosystema 1993; 6: 1-12.
29. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microb Rev 2000; 13: 236-301. (Pubitemid 30205427)
30. Van Burik JA, Schreckhise RW, White TC, et al. Comparison of six extraction techniques for isolation of DNA from f lamentous fungi. Med Mycol 1998; 36: 299-303.
31. Garcia-Hermoso D, Hoinard D, Gantier JC, et al. Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa. J Clin Microbiol 2009; 47: 3862-3870.
32. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi, Approved standard-Second ed. CLSI document M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
33. Alastruey-Izquierdo A, Castelli M V, Cuesta I, et al. In vitro activity of antifungals against zygomycetes. Clin Microbiol Infect 2009; 15: 71-76.
34. Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S. In vitro susceptibilities of 217clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother 2007; 51: 2587-2590. (Pubitemid 47047341)
35. Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003; 51: 45-52. (Pubitemid 36163826)
36. Singh J, Rimek D, Kappe R. In vitro susceptibility of 15 strains of zygomycetes to nine antifungal agents as determined by the NCCLS M38-A microdilution method. Mycoses 2005; 48: 246-250. (Pubitemid 40965943)
37. Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR. In vitro activities of posaconazole, itraconazole, voriconazole amphotericin B, and f uconazole against 37 clinical isolates of zygo-mycetes. Antimicrob Agents Chemother 2002; 46: 1581-1582. (Pubitemid 34415351)
38. Torres-Narbona M, Guinea J, Martinez-Alarcon J, Pelaez T, Bouza E. In vitro activities of amphotericin B, caspofungin, itraconazole, posaconazole, and voriconazole against 45 clinical isolates of zygomycetes: comparison of CLSI M38-A, Sensititre YeastOne, and the Etest. Antimicrob Agents Chemother 2007; 51: 1126-1129. (Pubitemid 46355313)
39. Dannaoui E, Afeltra J, Meis JF, Verweij PE. In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents. Antimicrob Agents Chemother 2002; 46: 2708-2711. (Pubitemid 34793494)
40. Gomez-Lopez A, Cuenca-Estrella M, Mellado E, Rodriguez-Tudela JL. In vitro evaluation of combination of terbinaf ne with itraconazole or amphotericin B against Zygomycota. Diagn Microbiol Infect Dis 2003; 45: 199-202. (Pubitemid 36349660)